News Search Results
Jul 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jul 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 22, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 22, 2025, 09:15 ET OrbiMed Promotes Mona Ashiya to General Partner
is a recognized leader in biotechnology investing," OrbiMed Managing Partner Carl Gordon said. "She has made significant contributions to the industry and to OrbiMed. We look forward to continuing to work with her to start and grow the next generation of exciting biotechnology companies." Since
More news about: OrbiMed
Jul 22, 2025, 09:00 ET Hatch.Bio Labs Introduces Advanced Vivarium Facility Following Successful Site Launch
Biotechnology and life sciences companies face unique operational and logistical challenges as they scale, which can distract them from the development of impactful
More news about: Hatch.Bio Labs
Jul 22, 2025, 09:00 ET BioMarin to Host Second Quarter 2025 Financial Results Conference Call and Webcast on Monday, August 4, 2025, at 4:30pm ET
https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Jul 22, 2025, 08:45 ET Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
("Avant" or the "Company"), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments in biotechnology, today announced that Vinicio Vargas, Chief Executive Officer (CEO) of Avant's partner, Ainnova Tech, Inc., (Ainnova),
More news about: MarketNewsUpdates
Jul 22, 2025, 08:42 ET Award-Winning Broadway, Television & Film Star Aaron Lazar Featuring NeuroSense CEO Alon Ben-Noon in a Special Live Podcast on ALS Science, PrimeC's Commercialization Strategies, and Community
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, updates today that in a live broadcast, NeuroSense CEO Alon
More news about: NeuroSense
Jul 22, 2025, 08:30 ET Halozyme to Report Second Quarter 2025 Financial and Operating Results
at least one major region and across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Jul 22, 2025, 08:00 ET Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
biology to efficiently deliver improved ADC cancer treatments, announced today that the Company's management will participate in the BTIG Virtual Biotechnology Conference being held on July 29-30, 2025. About Whitehawk Therapeutics Whitehawk Therapeutics is an oncology therapeutics
More news about: Whitehawk Therapeutics, Inc.
Jul 22, 2025, 08:00 ET Codagenix Awarded PATH Subcontract to Develop Stabilized Novel Oral Polio Vaccine Candidates
N.Y., July 22, 2025 /PRNewswire/ -- Codagenix Inc., a clinical-stage biotechnology company, today announced a collaboration agreement with PATH funded by a grant from the Gates Foundation to apply its proprietary synthetic biology
More news about: Codagenix Inc.
Jul 22, 2025, 08:00 ET Avant Technologies' Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
("Avant" or the "Company"), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments in biotechnology, today announced that Vinicio Vargas, Chief Executive Officer (CEO) of Avant's partner, Ainnova Tech, Inc., (Ainnova),
More news about: Avant Technologies Inc.
Jul 22, 2025, 08:00 ET Diakonos Oncology Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating DOC1021 (dubodencel) for Glioblastoma
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced that the first patient has been
More news about: Diakonos Oncology
Jul 22, 2025, 08:00 ET A novel oral treatment for Alzheimer's: Actinogen's pivotal trial currently recruiting participants in the US
Medical Limited About Actinogen Medical Actinogen Medical (ACW) is an ASX-listed, biotechnology company in the late clinical stages of development for Xanamem® (emestedastat), its novel oral therapy for Alzheimer's disease and depression. The
More news about: Actinogen Medical Limited
Jul 22, 2025, 07:34 ET Nikko AM Introduces ChiNext ETF on Singapore Exchange under ETF Link, Tied to E Fund's Onshore ETF
(SZSE). Over 90% of the index is weighted in strategic emerging industries such as next-generation information technology, new energy vehicles, and biotechnology, and includes leading companies like CATL, Inovance, InnoLight, Mindray, and Sungrow. The index constituents have demonstrated strong fundamentals,
More news about: E Fund Management
Jul 22, 2025, 07:00 ET Nanoscope Therapeutics Publishes Mechanism of Action Details for Proprietary Broadband and Fast Multi-Characteristic Opsin Technology
Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene therapies for patients suffering vision loss from retinal degenerative diseases,
More news about: Nanoscope Therapeutics
Jul 22, 2025, 06:00 ET Exyte receives Facility Diamond Partner Award for CATL Battery Cell Gigafactory in Germany
developed over more than a century, the company serves clients in the sophisticated markets of semiconductors, battery cells, pharmaceuticals, biotechnology, and data centers. Exyte offers a full range of services from consulting to managing the implementation of complete solutions with the highest standards
More news about: Exyte
Jul 22, 2025, 06:00 ET Danaher Reports Second Quarter 2025 Results
three and six-month periods ended June 27, 2025 ($432 million pretax as reported in this line item, $328 million after-tax) and a facility in the Biotechnology segment recorded in the six-month period ended June 27, 2025 ($15 million pretax as reported in this line item, $11 million after-tax).
More news about: Danaher Corporation
Jul 22, 2025, 03:52 ET METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
nonprofit scientific organization dedicated to advanced drug delivery. At this year's meeting, METiS Technologies stood out as the only Chinese biotechnology company participating with a featured poster presentation. Dr. Hongming Chen, Co-founder and Chief R&D Officer
More news about: METiS Technologies
Jul 22, 2025, 03:00 ET SkylineDx's Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
www.merlinmelanomatest.com. About SkylineDx SkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology inflammatory, and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Jul 22, 2025, 01:48 ET Vicebio, next-generation vaccine biotech, to be acquired by Sanofi for US$1.6 billion
New York City, with over $6.5 billion in capital primarily focused on supporting emerging life sciences and biotechnology companies. For more information, please visit:
More news about: Vicebio
Jul 21, 2025, 16:05 ET Tyra Biosciences Announces Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series
July 21, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
Jul 21, 2025, 15:45 ET AusperBio Receives China CDE Clearance to Advance AHB-137 into Phase III Clinical Trial for Chronic Hepatitis B
2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, today announced that the China Center for Drug
More news about: AusperBio Therapeutics Inc.
Jul 21, 2025, 11:31 ET Nanotechnology in Agriculture Market Size to Grow USD 6743.3 Million by 2030 with a CAGR of 12.7% | Valuates Reports
efficiency, and food security, stakeholders across academia, government, and industry are collaborating to advance adoption. The convergence of biotechnology, smart systems, and material science is expected to propel the market forward. As barriers to scalability and regulation continue to ease, nanotechnology
More news about: Valuates Reports
Jul 21, 2025, 11:30 ET Electronic Data Interchange Market Size to Grow USD 74.36 billion by 2031, Rising Digital Transformation Across Various Industries Propels | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners